Title : Inhibition of TGF-β Signaling in Tumor Cells by Small Molecule Src Family Kinase Inhibitors.

Pub. Date : 2017

PMID : 28044939






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In a series of studies carried out over the last couple of years in various cell types, it was observed that the experimentally used Src family kinase inhibitors PP1 and PP2 and the clinically used Src/Abl inhibitors AZM475271 and dasatinib are potent inhibitors of TGF-beta mediated cellular responses such as Smad and p38 mitogen-activated protein kinase phosphorylation, Smad-dependent transcriptional activation, growth inhibition, epithelial-mesenchymal transition (EMT), and cell motility. Dasatinib ABL proto-oncogene 1, non-receptor tyrosine kinase Homo sapiens